DV
Dividend Vision

CDXS — Codexis Inc

Codexis Inc (CDXS)

Total return is -88.2% over the past 16.3 years, 844.3 points behind SPY at 756.1%. Its deepest 1-year drawdown was 68.4%.

# Summary CDXS is an individual equity stock rather than a diversified ETF. The company operates in the biotechnology and synthetic biology sector, focusing on enzyme engineering and biocatalysis solutions for pharmaceutical and chemical manufacturing. As a single-stock holding with no dividend distribution rate and no associated expense ratio, it is suited for investors seeking direct exposure to a specialized biotech company rather than those pursuing passive dividend income.

CDXS key facts

Asset type
Stock
Asset class
Equity
Inception date
04/22/2010
Last close
$1.56
Market cap
$203,608,320
Average volume
1244500.0
Beta
2.5
Payout ratio
0.0
Forward P/E
149.2537
EPS
$-0.35